Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan 2;11(1):23.
doi: 10.3390/life11010023.

Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art

Andrea Bassi  1 , Teresa Russo  2 , Giuseppe Argenziano  2 , Carlo Mazzatenta  1 , Elisabetta Venturini  3 , Iria Neri  4 , Vincenzo Piccolo  2
Affiliations

Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art

Andrea Bassi et al. Life (Basel). .

Abstract

SARS-CoV-2 infection has spread all over the world in the last year, causing millions of COVID-19 cases among humans with a large variability of symptoms and signs, including those on the skin. Among these, a contemporary cluster of chilblain-like lesions with no certain relationship with the infection has been reported. The aim of this paper is to delineate a profile of chilblain-like lesions and to establish the state-of-the-art knowledge about this new phenomenon.

Keywords: COVID-19; chilblain-like lesions; skin manifestation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Erythematous–edematous (A) and bullous (B) chilblain-like lesions: (A) 13-year-old male, COVID-19 negative; he had spontaneous resolution in one month; (B) 12-year-old male, COVID-19 negative; resolution was achieved with daily application of high-potency steroids.
See this image and copyright information in PMC

References

    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. Recalcati S. Cutaneous manifestations in COVID-19: A first perspective. J. Eur. Acad. Dermatol. Venereol. 2020;34 doi: 10.1111/jdv.16387. - DOI - PubMed
    1. Piccolo V., Neri I., Filippeschi C., Oranges T., Argenziano G., Battarra V.C., Berti S., Manunza F., Fortina A.B., Di Lernia V., et al. Chilblain-like lesions during COVID-19 epidemic: A preliminary study on 63 patients. J. Eur. Acad. Dermatol. Venereol. 2020;34 doi: 10.1111/jdv.16526. - DOI - PMC - PubMed
    1. Piccolo V., Bassi A. Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions. J. Am. Acad. Dermatol. 2020;83:e231. doi: 10.1016/j.jaad.2020.05.077. - DOI - PMC - PubMed
    1. Cleach L.L., Dousset L., Assier H., Fourati S., Barbarot S., Boulard C., Bourseau C.Q., Cambon L., Cazanave C., Colin A., et al. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing. Br. J. Dermatol. 2020;183:866–874. doi: 10.1111/bjd.19377. - DOI - PMC - PubMed

LinkOut - more resources